Search

Vetoquinol SA

Geschlossen

BrancheGesundheitswesen

78.9 1.02

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

77.5

Max

79.7

Schlüsselkennzahlen

By Trading Economics

Einkommen

-9.8M

25M

Verkäufe

-17M

258M

KGV

Branchendurchschnitt

15.392

37.257

Dividendenrendite

1.13

Gewinnspanne

9.734

Angestellte

2,497

EBITDA

-12M

48M

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.13%

2.94%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

17M

926M

Vorheriger Eröffnungskurs

77.88

Vorheriger Schlusskurs

78.9

Nachrichtenstimmung

By Acuity

50%

50%

183 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Vetoquinol SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Okt. 2025, 20:45 UTC

Ergebnisse

Costco Wholesale Sales Climb in September, Early October

8. Okt. 2025, 20:12 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

TaskUs Shares Fall After Holders Reject Take-Private Deal

8. Okt. 2025, 16:39 UTC

Wichtige Markttreiber

Mining Shares Rise as Gold Prices Soar

8. Okt. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. Okt. 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8. Okt. 2025, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Finance Acquisition Using Internal Funds

8. Okt. 2025, 23:17 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8. Okt. 2025, 23:16 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8. Okt. 2025, 21:54 UTC

Market Talk
Ergebnisse

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8. Okt. 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8. Okt. 2025, 21:26 UTC

Market Talk
Ergebnisse

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8. Okt. 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8. Okt. 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Will Remain a Publicly Traded Co >TASK

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8. Okt. 2025, 18:45 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8. Okt. 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Okt. 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8. Okt. 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8. Okt. 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8. Okt. 2025, 15:43 UTC

Akquisitionen, Fusionen, Übernahmen

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8. Okt. 2025, 15:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Vetoquinol SA Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

72.6 / 75.1Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

183 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat